Sleep deprivation reduces the lymphocyte count in a non-obese mouse model of type 1 diabetes mellitus

被引:5
|
作者
Ruiz, F. S. [1 ]
Andersen, M. L. [1 ]
Zager, A. [1 ]
Martins, R. C. S. [1 ]
Tufik, S. [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Psicobiol, Escola Paulista Med, BR-04024002 Sao Paulo, SP, Brazil
关键词
sleep deprivation; stress; lymphopenia; diabetes; non-obese diabetic mouse; Swiss mice;
D O I
10.1590/S0100-879X2006005000086
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The objective of the present study was to determine whether sleep deprivation ( SD) would promote changes in lymphocyte numbers in a type 1 diabetes model (non-obese diabetic, NOD, mouse strain) and to determine whether SD would affect female and male NOD compared to Swiss mice. The number of lymphocytes in peripheral blood after 24 and 96 h of SD ( by multiple platform method) or equivalent period of time in home-cage controls was examined prior to the onset of diabetes. SD for 96 h significantly reduced lymphocytes in male Swiss mice compared to control (8.6 +/- 2.1 vs 4.1 +/- 0.7 10(3)/mu L; P < 0.02). In male NOD animals, 24- and 96-h SD caused a significant decrease of lymphocytes compared to control ( 4.4 +/- 0.3 vs 1.6 +/- 0.5; P < 0.001 and 4.4 +/- 0.3 vs 0.9 +/- 0.1 10(3)/mu L; P < 0.00001, respectively). Both 24- and 96- h SD induced a reduction in the number of lymphocytes in female Swiss ( 7.5 +/- 0.5 vs 4.5 +/- 0.5, 4.4 +/- 0.6 +/- 103/ L; P < 0.001, respectively) and NOD mice (4 +/- 0.6 vs 1.8 +/- 0.2, 1.2 +/- 0.4 10(3)/ L; P < 0.01, respectively) compared to the respective controls. Loss of sleep induced lymphopenia in peripheral blood in both genders and strains used. Since many cases of autoimmunity present reduced numbers of lymphocytes and, in this study, it was more evident in the NOD strain, our results suggest that SD should be considered a risk factor in the onset of autoimmune disorders.
引用
收藏
页码:633 / 637
页数:5
相关论文
共 50 条
  • [1] Sleep deprivation reduces lymphocytes in non-obese diabetic (nod) mouse model of type 1 diabetes mellitus
    Ruiz, F. S.
    Andersen, M. L.
    Zager, A.
    Martins, R. C.
    Tufik, S.
    SLEEP, 2008, 31 : A120 - A121
  • [2] EFFECTIVENESS OF PROBISAN® IN THE PREVENTION OF NON-OBESE DIABETIC MOUSE TYPE 1 DIABETES MELLITUS
    Cabello Olmo, M.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 52 - 52
  • [3] Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
    S.-M. Lee
    H. Yang
    D. M. Tartar
    B. Gao
    X. Luo
    S. Q. Ye
    H. Zaghouani
    D. Fang
    Diabetologia, 2011, 54 : 1136 - 1146
  • [4] Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes
    Lee, S. -M.
    Yang, H.
    Tartar, D. M.
    Gao, B.
    Luo, X.
    Ye, S. Q.
    Zaghouani, H.
    Fang, D.
    DIABETOLOGIA, 2011, 54 (05) : 1136 - 1146
  • [5] Leptin concentration in non-obese and obese children with type 1 diabetes mellitus
    Verrotti, A
    Basciani, F
    De Simone, M
    Morgese, G
    Chiarelli, F
    BIOMEDICINE & PHARMACOTHERAPY, 2000, 54 (02) : 69 - 73
  • [6] Type 2 diabetes mellitus in a non-obese mouse model induced by Meg 1/Grb10 overexpression
    Yamamoto, Yoshie
    Ishino, Fumitoshi
    Kaneko-Ishino, Tomoko
    Shiura, Hirosuke
    Uchio-Yamada, Kozue
    Matsuda, Junichiro
    Suzuki, Osamu
    Sato, Katsunori
    EXPERIMENTAL ANIMALS, 2008, 57 (04) : 385 - 395
  • [7] Leptin levels in non-obese and obese children and young adults with type 1 diabetes mellitus
    Verrotti, A
    Basciani, F
    Morgese, G
    Chiarelli, F
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (01) : 49 - 53
  • [8] Development of a Non-Obese Mouse Dietary Model of Gestational Diabetes
    Pennington, Kathleen A.
    Pollock, Kelly E.
    Kaiser, Jennifer A.
    Schulz, Laura C.
    REPRODUCTIVE SCIENCES, 2015, 22 : 179A - 180A
  • [9] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Christophe Bardin
    Estelle Nobecourt
    Etienne Larger
    François Chast
    Jean-Marc Treluyer
    Saik Urien
    European Journal of Clinical Pharmacology, 2012, 68 : 961 - 968
  • [10] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Bardin, Christophe
    Nobecourt, Estelle
    Larger, Etienne
    Chast, Francois
    Treluyer, Jean-Marc
    Urien, Saik
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 961 - 968